Navigation Links
The SDX® System: Unique respiratory gating system significantly improves tumor treatment accuracy - now available in the United States

The SDX® Respiratory Gating System, trusted by nearly 200 of the top radiation centers in 16 countries, has reached its 20th anniversary of worldwide use. Introduced in the US over the past two years, SDX® is now in routine use at top universities including University of Pennsylvania, University of Michigan, University of Maryland, University of California San Francisco—and 30% of proton centers nationwide including Miami Cancer Institute (Baptist Health South Florida).

Developed by industry leader DYN’R Medical Systems, SDX® has been shown to be the most effective respiratory gating system, due to its unique incorporation of direct lung volume measurement with clear bio-visual feedback. The system significantly increases precision in the treatment of moving tumors, providing therapists real-time internal information and allowing for increased dosages, while sparing nearby organs and healthy tissue. A video goggle system increases patient confidence and mastery of the DIBH (deep inspiration breath hold) technique with a 95% success rate.

“We chose the SDX® System to help avoid critical structures during radiation therapy treatments,” says the radiation oncology team at Cleveland Clinic Florida. “It allows us to better serve our patients, has increased safety and the overall quality of radiation therapy treatments, especially during our SBRT cases."

Tumors that move due to patient breathing, such as those located in the chest or abdomen, have always presented a challenge to radiation oncologists and physicists. In the past 20 years, several advancements in radiation delivery technology have helped to conform the radiation dose to the targeted tumor, yet adverse effects are still common due to difficulty in sparing surrounding tissue. The SDX® Respiratory Gating System greatly enhances tracking of these moving tumors, allowing for precise targeting with increased dosages—while sparing nearby organs and healthy tissue. Its unique patient visual guidance enables a 95% success rate in DIBH technique mastery.

SDX® "consistently lowers the mean and maximum doses to the organs at risk by about 15-30% and significantly reduces the treated target volume,” concluded a 2019 Maryland Proton Treatment Center study. A 2015 article in the Journal of Applied Clinical Medical Physics indicated that SDX® shows “statistically significant decreases in heart and LAD dose metrics over all patients and is a valuable adjunct to modern breast treatment techniques.”

Additionally, the SDX® Respiratory Gating System offers many unique benefits for therapists and treatment centers. SDX offers easy daily calibration in under one minute, and is easily portable between treatment rooms and C.T. It is compatible with every radiation delivery system, and offers Synchronization options with all Varian treatment machines, IBA's Proteus Plus and Siemens Somatom.

SDX® is now offering live webinars for interested oncologists, physicists, therapists and administrators. Presentations include a video demonstration of SDX® treatment, plus an exploration of the technology and its proven benefits, as well as presentations by clinicians and experts. Interested parties may visit for more information, or call Annabelle Lorenzo, Director of U.S. Sales, at (786) 862-3539.

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related biology technology :

1. New Approaches in Immunogenicity Assessment Using the New SQiDlite™ System: Case Study Analysis, New Life Science Webinar Hosted by Xtalks
2. Cutting Edge Spine Receives FDA 510(k) Clearance for EVOS System: Lumbar Interbody Technology Includes Proprietary Implant Manufactured with PEEK-OPTIMA HA Enhanced
3. Verdad Media’s Unique MANIS Technology Means Better Reputation Management Results for Clients
4. APPLIED PHYSIOLOGY® Receives key US Patent Award for its Unique NAVIGATOR™ Technology
5. Leading Chemical Manufacturer Expands Biobased Offering through Unique Distribution of Proven Green Spill Absorbent
6. Marrone Bio Innovations Files Patent for a Unique Bacillus Species
7. Biotrial, a Successful Leading CRO, Continues to Expand its Activities, Creating a Unique Neuroscience Pool of Talent and Capabilities: Biotrial Neuroscience
8. Unique Extracellular Matrix Used in Patient Successfully Treated for Flesh Eating Bacteria
9. Dr. Vasquez at the Connecticut Plastic Surgery Group Now Offers the Unique Crisalix 3D Simulations for Facial Aesthetics and Breast Augmentation
10. InstantGMP Announces Release of Unique Electronic Batch Record Software as a Service for Just $99/mo
11. Syngenta Opens Unique $72 Million Advanced Crop Lab
Post Your Comments:
(Date:7/31/2020)... ... July 30, 2020 , ... ... today announced the release of its signature product called Beacon - a ... and other field medical professionals. , Beacon helps MSLs streamline communication ...
(Date:7/18/2020)... , ... July 16, 2020 , ... After research model ... completion of a great surgery is only the beginning of a successful study, while ... community. , Join Brad Gien, Global Head of Surgery from Envigo in ...
(Date:7/18/2020)... DAYTON, Ohio (PRWEB) , ... July 16, 2020 ... ... clinical data solutions to aid in the early detection and prevention of high-burden ... partnership to enable US-based hospitals and healthcare organizations to utilize existing data in ...
(Date:7/10/2020)... ... July 08, 2020 , ... ... a significant expansion of laboratory operations through its COVID-19 testing service, Bode-CARES ... programs. , Bode-CARES provides a turnkey solution that includes a ...
Breaking Biology Technology:
(Date:8/5/2020)... Fla. (PRWEB) , ... August 05, 2020 , ... Regenative ... cover two new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly allografts ... defect using a syringe. The company’s solutions are the first Wharton’s jelly allograft product ...
(Date:7/18/2020)... ... 2020 , ... A study has been published in the ... noise control device to attenuate typical noises in a simulated neonatal intensive care ... sounds from patient monitors, ventilators and other bedside devices that would affect the ...
(Date:7/2/2020)... (PRWEB) , ... July 01, 2020 , ... ... presented its phase 1a findings of Neihulizumab, a biologic for the treatment of ... June 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson ...
Breaking Biology News(10 mins):